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1. Introduction 
Numerous cell types were shown to possess ~- 
adrenergic receptors coupled to adenylate cyclase. 
Using radiolabeled high affinity/3-adrenergic blockers, 
it became possible to determine the exact number o f  
.t3-receptors per cell. Most cells [1--11] were found to 
possess a small niimber o f  receptors which varies 
between a few hundred to a few thousand receptors 
per cell. Recently it was demonstrated that rat skeletal 
myoblasts grown in culture (L6P cells) [12] and a 
strain of  HeLa cells [13] possess a large number o f  
/3-adrenerDc receptors. In this communication we 
report on the visualization of/3-adrenoreceptor sites 
by the use of  the fluorescent/3-adrenergic blocker 9- 
m~L~oacridino-propanolol (9-AAP) [14,15].  It will be 
shown that the capability to visualize the/3-receptors, 
using a fluorescent/3-blocker, is limited by receptor 
density on the cell surface. 
~i'he fluorescent/3-blockers 9-ASP and DAPN [14] 
have been used successfully to map .B-adrenergic recep- 
tors in vSvo [ i5 - -22] .  In th%e studies the fluorescent 
B-blockers were first injected in vivo into the tail vein 
of  rats or mice; then the organs wer~ frozen, cut in a 
' cryostat, and subsequently the sections were sub- 
jected to  fluorescence microscopy. Using thi3 techni- 
que distinct cells within the tissues examined which 
possess/3-adrenergic re eptors on their surface were 
identified [15--22]. These findings indicate that r_he 
Abbreviations: 9-AAP, DL-N-(2-hydroxy-3-naphthyloxy- 
propyl)-N*-9-acridino-isopropylenediamine or 9-amino- 
acridinopropranolot; DAPN, DL-N-(2-hvdroxy-3-naphthyloxy- 
propyl)-N'-dansylethylenediamine or dansyt analogae of 
proprano lo l  
receptor density o f  these cells is high enough to 
enable their visualization. An attempt will be made 
to correlwte zhe findings in vivo with those reported 
in this study on cells grown in culture. 
2. Experimental 
2.1. Growth o f  cells 
2.1 .i. L6P Cells 
Skeletal muscle cells (L6P cells) were grown in 
culture, as described [1].  Cells were removed from 
the growth bottles using EDTA and counted, as 
described [12].  Protein was determined in order to 
established no. cells/rag protein. Since trypsin is often 
used to remove cells from tissue culture dishes, it was 
also used to remove L6P cells from the tissue culture 
bottles in another set of  experiments, according to the 
foUowing procedure: The growth medium was re- 
moved from the tissue culture bottle and the cells 
were incubated with 50 ml 130 mM saline, containing 
20 mM Tris--HCl buffer, pH 7.4, and 500/2g/ml 
trypsin for 30 rain at 37°C. The cells were detached 
from the bott!e, centrifuged at 500 × g, and washed 
twice with trypsin-free sMine containing buffer. 
2.1.2. HeLa Cells 
Cells were grown for 3 days at 37°C in M-199 
medium, containing 10% calf serum inactivated at 
56°C for 30 rain. Ceils were removed from the growth 
bottle using a solution of  140 mM NaCI, 10 mM 
Tris--HCl, pH 7.4, 10 mM Nucose, and 2 told EDTA.  
2.1.3. Turkey erythrocytes and $49 lymphoma cells 
Turkey erythrocytes were prepared as described 
[12,23]. 
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2.2. Binding o f  [ ~: : I ] t t rT  
[~zS[]HYP bh~dhag to intact  cells and  to cell 
membranes  was conducted  as described [7 ,12] .  
2.3. Protein determination 
Protein was determined using the method [24] .  
According to the prote in  determinat ion ,  it was found 
that 1.0 mg total  prote in = 2.88 × 10 ~ L6P cells and 
7.1 X I0 s HeLa cells, respectively. 
2 A.  Fluorescence microscopy o f  intact cells 
Washed L6P cells or HeLa cells were suspended in 
130 mM NaC1, 20 rnN1Tr~s--HCI, pFi 7.4 and 1O mM 
glucose. Cells were m~ed with 1.3 X l0  -s M 9-AAP 
w~th or w i thout  3.3 X 10 -6 M L-proprano!oi  or 
D-propranolol .  F luorescence was viewed and photo-  
graphs were taken using a N ikon  f luorescence m~cro- 
scope equipped wi th  a N ikon  M-355 camera. "['he f-din, 
Kodak  400  ASA,  was developed with the corre- 
sponding 400 ASA developer. Exposure t ime was 
2 rain using the B fdters as f luorescence exc i tat ioa 
fdter. Pictures were taken with in  10 min  after mix ing 
the cells with the f luorescent dye and the propranolo l  
stereoisomers. The intens i ty  o f  f luorescence was found 
to decay upon cell death,  which may occur  wizhin 30 
rain subsequent  to the exposure o f  the cells to f luo- 
rescent dye under  the cover slide. 
3. Results 
3.1.Binding o f  [12SI]HYP to intact cetls and the 
ef fect  o f  trypsin 
L6P ceils and HeLa cells possess 80 009 receptors 
and 37 000 receptors, respectively (data not  shown).  
In  both  cases the cells possess a single class of  [~zs!]_ 
I-I~'P receptor-b inding sites. 
Removal  o f  L6P cells f rom the tissue culture bott le  
using trypsin results ':;~ a 5-fold reduct ion  in the 
content  of~-receptors a compared to ceUs removed. 
by EDTA t reatment  ( f ig. l ) .  
3.2. Stereospecific f luorescence visualization o f  
B-receptors 
In  fig.2 it can be seen that  L6P and HeLa cells 
b/rid 9-AAP,  presumably  to the/~-receptors. The 
appearance o f /n tense  f luorescence dots can be inh ib i ted 
by L-propranolol  but  not  by D-propranolol .  The f luo- 
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Fig.I. The binding of [~2S[]HYP to intact L6P ceils_ The 
binding data is represented in the form ofa Scatchard plot. 
The non-specific binding was measured in the prese~ce of 
1.0 × 10 -s M L-propranolol, as described [ 12]. Cel!s 
removed by trypsin treatment exhibited identical extent of 
non-specific [~asl]HYP bindhg as cells removed by EDTA. 
(e - -e )  L6P cells removed by EDTA treatment. (o - -o )  L6P 
.'=ella removed ['y trypsin treatment. 
rescence pattern observed when tile cells are mixed 
with 9-AAP in the presence o f  L-propranolo l  is rather 
faint. On the other hand,  when the cells are mixed 
with 9-AAP in the presence o f  the inactive stereo= 
isomer D-propanolo l ,  the intense f luorescence pattern 
remaLns essential ly unchauged.  The hazy f luorescence 
observed/n  the presence or absence of  L-proprano!ol  
iS evenly distr ibuted on the cell surface, and probably  
represents non-specif ic sotubi l izat ion o f  9-AAP in the 
cell membrane .  Sim~ar exper iments  using $49 gl ioma 
cells, wh/ch possess about  200- -300 receptors/cel l  
[8] ,  and turkey erythrocyte gJaosts, which possess 
about  1000 receptors/cell [ t , i2 ] ,  did not  reveal f luo- 
rescent dots except for the non-specif ic,  evenly- 
d istr /buted faint  fluorescence. 
4. Discussion 
4_ 1 _ Number  o f  B-reeepto~'s per  cell 
In  this s tudy we have shown that  the f luorescent 
15 ° 
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Fig.2. Fluorescence visualization o f  ~-receptors on L6P cells and on HeLa cel~s. (a) L6P cells in the presence of  1.0 X 10 -s M 
9-AAP. (b) L6P cells in the presence of  1.0 × I0 -s M 9-AAP and 3.0 × [0 -6 M L-propranoloL (e) HeLa cells in the presence o f  
1.0 X I0 -s M 9-AAP. The bar in a -c  represents 40 #m. 
ana logue  o f  p roprano lo ! ,  9 -AAP ,  wh ich  b inds  s te reo-  tors  per / l rn  2 are t reated  w i th  9 -AAP ,  no  f luorescence  
spec i f i ca l ly  to, the  13-adrenoreceptors,  a l lows the  cap. be detected ,  Thus ,  fo r  example, turkey erythro- 
~sua l i za t ion  o f  the /3 -adrenerg ic  receptors ,  p rov ided  cyte  membranes ,  nat ive  tu rkey  ery throcytes ,  o r  $49  
that  the  dens i ty  o f  the  receptors  is h igh  enough,  l y rnphoma cel ls do  not  reveal  spec i f i c  f luorescence  
When cei ls  o r  membranes  possess ing on ly  a few recep-  sta'_'ning us ing 9 -AAP  (see also tab le  1). Skel_etal myo-  
Table 1 
The density of/3-adrenergic receptors in a number of  cell types 
Cell type Receptors/cell Averago density 
(recep tots/gin 2) 
Turkey erythrocyte 1100 a 8 
$49 lymphoma 200-300  b <8 
L6P (skeletal muscle) 80 000 160 c 
HeLa 37 000 d 100--200 d
a From [1,12] 
b From [8.1 
c This study and [12] 
dThis study 
160 
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blasts grown in culture (L6P cells) and HeLa cells 
possess 30--80-fold more receptors/cell (fig. [) than 
turkey erythrocytes (table 1). Considering the surface 
area o f  L6P cells and o f  HeLa cells used, it can be 
calculated that the receptor density is 12--20-fold 
higher than in turkey erythrocytes.  All other types o f  
cells, which were found to possess ~-adrenergic recep- 
tors, were demonstrated to possess a receptor density 
equal or lower to that o f  turkey erythrocytes,  It  is 
clear, therefore, that the ability to visualize specific 
9-AAP fluorescence depends directly on the density 
of  the ~-adrenergic receptors. 
1t is interesting that rat skeletal membranes 
prepared f rom the thigh muscle o f  two-day old rats 
possess only 0.38 pmol/mg/~-receptors as measured 
by [12sI] HYP binding (D.A. and A.L., unpublished). 
The L6P skeletal muscle cells used in our studies are 
derived f rom this thigh muscle tissue [25].  
4.2. Stereospecificity o f  9-AAP binding 
The fluorescent analogue is a competit ive inhibitor 
for L-epinephrine in the adenylate cyclase reaction, 
and competit ively inhibits [12sI] HYP binding to 
~-receptors [ 14]. In in vitro fluorescence ×periments 
only L-propranolol and L-epinephrine are capable o f  
displaying 9-AAP from the/~-adrenergic receptor o f  
turkey erythrocyte membranes [14].  The stereo- 
specificity of  9-AAP binding is also revealed in the 
binding o f  the fluorescent compound to the intact 
L6P cells (fig.2). The active isomer L-propranolo! dis- 
places effectively the fluorescent/3-blocker f rom the 
cell surface, leading to a significant reduction in fluo.- 
rescence intensity, whereas D-proprano[ol is ineffec- 
tive. The hazy fluorescence shown in the presence o f  
L-propranolol probably reflects the non-specific solu- 
bility o f  tire compound in the cell membrane.  I t
should be pointed out that the faint fluorescence was 
a typical observation i  aU cells examined which 
possess low receptor density, such as $49 lymphoma 
cells and turkey erythrocytes.  
4.3. The number and distrlbutlon o f  O-receptors on 
cell surfaces 
The fluorescent analogues o f  propranolol ,  9- 'AAP 
and DAPN, can be used successfu~y to localize/3- 
adrenerNc receptors m vivo [ 14--22].  In these experi- 
ments the fluorescent analogue was injected in vivo 
into the animal. A short time thereafter the animal 
was sacrificed, the organs frozen, and the cryostat 
sections visualized using fluorescence microscopy..-r_n 
these studies it was demonstrated that only cell bodies 
possessing ~-adrenergic receptors become stained with 
the fluorescent analogues. Cells such as turkey 
erythrocytes or S49 !ymphoma cells, which possess 
only a few receptors per/~m 2 (table i ) .  do not reveal 
any specific fluorescence when exposed to 9-AAP. 
Ceils with high receptor de_n_sity such as L6P cells o: 
HeLa cells fluoresce strongly when exposed to 9-AAP. 
Therefore, cell bodies which fluoresce subsequent to 
injection o f  9-AAP ~n vivo possess a high density o f  
~-receptors. The fluorescence pattern obscured in vivo 
inaicates domains in which the receptors are clustered 
[19].  
4 A. Distribution o f  receptors 
From fig.2 it is apparent hat the fluorescence dots 
distribution on the cell body is not homogeneoas.  
The fl-adrenoreceptors could be clustered in domains 
which are not evenly distributed on the cell mem- 
brane. Clustering could be induced by the fluorescent 
/3-blocker but could pre-exist on the membrane.  This 
question is currently under investigation. 
4.5. The turnover nv:mber of  adenylate (~'clase 
Skeletal muscle myobiasts grown in culture (L6 
cells) exhibit a very ihigh L-epinephrine dependent 
adenylate cyc!ase activity [26].  The value reported 
[27] was 500 pmol  cAMP/rag eel!s/rain. Assumhlg a 
stoichiometric relationship between the/3-adrenergic 
receptor and the cyclase, a value of  2.88 X'106 cells 
(this study)/mg protein, and a turnover number for 
adenylate cyclase of 1400 rain -x [2] ,  one can cab 
culate that the L6 ceils used [27] possess 
500 6.03 X 1023 X 10 -Is 
- -X  
1400 2.88 X 10 6 
= 75 000 receptors/cell. 
The value found by direct [~2sI]HYP-bind':ng r__~easure- 
ments to intact cells in this study, as well as [12],  
was found to be g0 009-84  000 receptors/cell. [t
appears therefore that the assumption made on the 
stoichiometric relationsMp between adenylate cyc!ase 
and the/3-adrenergh: receptor, origin~ly made for the 
turkey erythrocyte cell ~2], is valid and may r~present 
a universal correlation between the receptor at1 d the 
enzyme. 
16! 
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5. Condu~ons  
The dens i ty  of/~-adrenergJc receptors on  the surface 
o f  re, t skeletal myob las ts  grown in cul ture (L6P) and 
on HeLa cells was found za be a lmost  two orders o f  
magn i tude  higher than in all o ther  cell types known 
to possess t3-adrene:gic receptors.  The high densi ty  o f  
/3-adreriergic receptors on  these ceils allows their  
• Asual izat ion by  f luorescence microscopy using the 
high af f in i ty  f luorescent/3-adrenergic b locker,  9-AAP.  
The f luorescence label ing o f  these receptors is stereo- 
speci:~c. F rom the f luorescence pat tern  observed, it is 
suggested that  the f3-receptors are c lustered in domains.  
The fl-adrenergic receptors o f  cells which possess a 
rather low density o f  receptors cannot  be visualized 
by this technique.  A compar ison between these f ind- 
ings and the establ ished abi l i ty o f  this compound to 
map fl:adrenergic receptors in vivo was made.  
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